Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Active-comparator, 8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects

NCT00949884 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00949884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Active-comparator, 8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2009
Completion date
January 31, 2010
Enrollment
941 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension